| mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
| mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.044 |
0.2 |
| mRNA |
vorapaxar |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.1 |
| mRNA |
vincristine |
CTRPv2 |
pan-cancer |
AAC |
-0.0088 |
0.8 |
| mRNA |
valdecoxib |
CTRPv2 |
pan-cancer |
AAC |
-6.6e-05 |
1 |
| mRNA |
tubastatin A |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.2 |
| mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
0.0067 |
0.8 |
| mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |
| mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.2 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.2 |